3,690
edits
Obesity: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
[https://pubmed.ncbi.nlm.nih.gov/1858735/ Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity] | [https://pubmed.ncbi.nlm.nih.gov/1858735/ Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity] | ||
1. Hannon TS, Arslanian SA. Obesity in Adolescents. New England Journal of Medicine. 2023;389(3):251-261. doi:10.1056/NEJMcp2102062 | |||
2. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016. Jama. 2018;319(16):1723-1725. doi:10.1001/jama.2018.3060 | |||
3. Boyland EJ, Nolan S, Kelly B, et al. Advertising as a cue to consume: a systematic review and meta-analysis of the effects of acute exposure to unhealthy food and nonalcoholic beverage advertising on intake in children and adults12. The American Journal of Clinical Nutrition. 2016/02/01/ 2016;103(2):519-533. doi:https://doi.org/10.3945/ajcn.115.120022 | |||
4. Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2)doi:10.1542/peds.2022-060640 | |||
5. Inge TH, Courcoulas AP, Jenkins TM, et al. Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults. The New England journal of medicine. May 30 2019;380(22):2136-2145. doi:10.1056/NEJMoa1813909 | |||
6. Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640. | |||
7. Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640. | |||
8. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185. | |||
9. American Society of Anesthesiologists. Patients Taking Popular Medications for Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests. Accessed 07/20/2023, www.asahq.org/about-asa/newsroom/news-releases/2023/06/patients-taking-popular-medications-for-diabetes-and-weight-loss-should-stop-before-elective-surgery | |||
10. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. May 28 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038 | |||
11. Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine. Dec 15 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601 | |||
12. Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. doi: 10.1111/dom.14725. Epub 2022 May 19. PMID: 35441470; PMCID: PMC9542252. | |||
13. Burke C.N., Voepel-Lewis T., Wagner D., Lau I., Baldock A., Malviya S, et. al.: A retrospective description of anesthetic medication dosing in overweight and obese children. Paediatric Anaesthesia 2014; 24: pp. 857-862. | |||
14. Diepstraten J., Chidambaran V., Sadhasivam S., Esslinger H.R., Cox S.L., Inge T. H, et. Al.: Propofol clearance in morbidly obese children and adolescents. Clinical Pharmacokinetics 2012; 51: pp. 543-551. | |||
15. Olutoye O.A., Yu X., Govindan K., Tjia I.M., East D.L., Spearman R, et. al.: The effect of obesity on the ED(95) of propofol for loss of consciousness in children and adolescents. Anesthesia and Analgesia 2012; 115: pp. 147-153. | |||